Commentary

At their trilateral summit at Camp David on August 18, U.S. President Joe Biden, South Korean President Yoon Suk Yeol and Japanese Prime Minister Fumio Kishida announced significant new steps toward a lasting structure for trilateral security cooperation. While their pledges fell short of a formal security agreement, the leaders committed to initiatives that demonstrate […]

China’s economic numbers do not paint a pretty picture. The International Monetary Fund, World Bank, and private sector forecasters have lowered their 2023 and 2024 China growth projections to around five and 4.5 percent, respectively.

The South Korean economy is noticeably sputtering, especially in comparison to stronger post-COVID recoveries elsewhere in Asia. Korea’s exports are down 15 percent year-on-year. Meanwhile, interest rate hikes by the Bank of Korea (BOK) to stem inflation have been largely successful but have hit the country’s USD 107 billion housing market and construction industry especially

Indian Prime Minister Narendra Modi’s sixth visit to the White House – and maiden state visit – outlined an ambitious vision for the future of U.S.-India ties, which he said were entering a period of “unprecedented trust” and were a “force for global good.” Echoing a similar message, U.S. President Joe Biden called the U.S.

In recent months, a growing chorus of analysts has argued that the U.S. dollar’s dominance is waning, with China’s renminbi (RMB) emerging as the leading replacement.

Full Paper (English): TAG Paper: Observations on Drug Pricing and Innovation in Japan ENG Full Paper (Japanese): TAG Paper: Observations on Drug Pricing and Innovation in Japan JPN Key Findings As the Government of Japan (GOJ) seeks to re-invigorate Japan’s pharmaceutical industry as a sector for innovation and growth, it can make impactful changes to specific pricing